Application Information

This drug has been submitted to the FDA under the reference 204078/001.

Names and composition

"BLOXIVERZ" is the commercial name of a drug composed of NEOSTIGMINE METHYLSULFATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204078/001 BLOXIVERZ NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 5MG per 10ML (0.5MG per ML)
204078/002 BLOXIVERZ NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 10MG per 10ML (1MG per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
203629/001 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 5MG per 10ML (0.5MG per ML)
203629/002 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 10MG per 10ML (1MG per ML)
204078/001 BLOXIVERZ NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 5MG per 10ML (0.5MG per ML)
204078/002 BLOXIVERZ NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 10MG per 10ML (1MG per ML)
207042/001 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 5MG per 10ML (0.5MG per ML)
207042/002 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 10MG per 10ML (1MG per ML)
208405/001 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 5MG per 10ML (0.5MG per ML)
208405/002 NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE SOLUTION/INTRAVENOUS 10MG per 10ML (1MG per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved